[Four cases of fatal lactic acidosis during biguanide therapy (author's transl)]. 1978

K Irsigler, and H Kritz, and L Kaspar, and H Lageder, and H Regal

Four case reports of lactic acidosis occurring during biguanide treatment (2 with phenormin, 2 with buformin) are analysed. Three of the patients died in a toxic state of lactic acidosis, whilst the fourth patient survived lactic acidosis, but died 11 days later due to myocardial infarction. In spite of serum biguanide levels within the therapeutic range, one patient had highly toxic hepatic levels of phenformin (13,500 ng/g tissue). Two factors are essential for the treatment of lactic acidosis: 1. rapid diagnosis: history of biguanide intake; clinical symptoms; acid-base imbalance; rapid lactate determination to establish the diagnosis. 2. therapy: correction of acidosis, insulin and glucose; shock treatment; forced diuresis and/or haemodialysis. From the high numbers of biguanide-treated diabetics and the incidence of lactic acidosis in other countries it can be assumed that this toxic side effect of biguanide treatment occurs relatively frequently in Austria too, but remains largely undetected.

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000138 Acidosis A pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up. Metabolic Acidosis,Acidoses,Acidoses, Metabolic,Acidosis, Metabolic,Metabolic Acidoses
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001645 Biguanides Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES. Biguanide

Related Publications

K Irsigler, and H Kritz, and L Kaspar, and H Lageder, and H Regal
December 1976, Schweizerische medizinische Wochenschrift,
K Irsigler, and H Kritz, and L Kaspar, and H Lageder, and H Regal
October 1978, Wiener klinische Wochenschrift,
K Irsigler, and H Kritz, and L Kaspar, and H Lageder, and H Regal
October 2003, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies,
K Irsigler, and H Kritz, and L Kaspar, and H Lageder, and H Regal
August 1977, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
K Irsigler, and H Kritz, and L Kaspar, and H Lageder, and H Regal
September 1976, Medizinische Klinik,
K Irsigler, and H Kritz, and L Kaspar, and H Lageder, and H Regal
May 1978, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
K Irsigler, and H Kritz, and L Kaspar, and H Lageder, and H Regal
July 1974, Wiener klinische Wochenschrift,
K Irsigler, and H Kritz, and L Kaspar, and H Lageder, and H Regal
September 1990, The Journal of the Association of Physicians of India,
K Irsigler, and H Kritz, and L Kaspar, and H Lageder, and H Regal
January 1981, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
K Irsigler, and H Kritz, and L Kaspar, and H Lageder, and H Regal
January 1979, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
Copied contents to your clipboard!